OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular markers in pancreatic cancer diagnosis
Marta Herreros‐Villanueva, Meritxell Gironella, Antoni Castells, et al.
Clinica Chimica Acta (2013) Vol. 418, pp. 22-29
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels
M. Hosein Aziz, Kostandinos Sideras, N. Ahmad Aziz, et al.
Annals of Surgery (2018) Vol. 270, Iss. 1, pp. 139-146
Closed Access | Times Cited: 221

Update on the management of pancreatic cancer: Surgery is not enough
Daniel Ansari, Adam Gustafsson, Roland Andersson
World Journal of Gastroenterology (2015) Vol. 21, Iss. 11, pp. 3157-3165
Open Access | Times Cited: 166

Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
Robert O’Neill, Alina Stoita
World Journal of Gastroenterology (2021) Vol. 27, Iss. 26, pp. 4045-4087
Open Access | Times Cited: 77

Prognostic value of preoperative [68 Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics
Jie Ding, Jiangdong Qiu, Zhixin Hao, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 6, pp. 1780-1791
Closed Access | Times Cited: 23

Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites
Iole Maria Di Gangi, Tommaso Mazza, Andrea Fontana, et al.
Oncotarget (2015) Vol. 7, Iss. 5, pp. 5815-5829
Open Access | Times Cited: 78

Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma
Qing Li, Hao Wang, George Zogopoulos, et al.
Oncotarget (2016) Vol. 7, Iss. 47, pp. 77838-77853
Open Access | Times Cited: 58

Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models
Claudio Ricci, Carlos Mota, Stefania Moscato, et al.
Biomatter (2014) Vol. 4, Iss. 1, pp. e955386-e955386
Open Access | Times Cited: 56

Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatment
Young Eun Lee, Anna Ju, Hwi Wan Choi, et al.
Journal of Controlled Release (2020) Vol. 326, pp. 310-323
Closed Access | Times Cited: 41

Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma
Fereshteh Rezagholizadeh, Fatemeh Tajik, Morteza Talebi Doluee, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

Antitumor activity of genetically engineered NK-cells in non-hematological solid tumor: a comprehensive review
Chinmayee Dash, Dhruba Sonowal, Prachi Dhaka, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer
Keiko Shinjo, Kazuo Hara, Genta Nagae, et al.
PLoS ONE (2020) Vol. 15, Iss. 6, pp. e0233782-e0233782
Open Access | Times Cited: 31

Electrochemiluminescence immunosensor for tumor markers based on biological barcode mode with conductive nanospheres
Shuping Du, Zhiyong Guo, Beibei Chen, et al.
Biosensors and Bioelectronics (2013) Vol. 53, pp. 135-141
Closed Access | Times Cited: 33

Evolving pancreatic cancer treatment: From diagnosis to healthcare management
Michèle Milella, Claudio Bassi, Ugo Boggi, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 169, pp. 103571-103571
Closed Access | Times Cited: 23

Luteolin and Gemcitabine Protect Against Pancreatic Cancer in an Orthotopic Mouse Model
Jodee L. Johnson, Vermont P. Día, Matthew A. Wallig, et al.
Pancreas (2014) Vol. 44, Iss. 1, pp. 144-151
Closed Access | Times Cited: 29

Application of glycoscience to the early detection of pancreatic cancer
Eiji Miyoshi, Yoshihiro Kamada
Cancer Science (2016) Vol. 107, Iss. 10, pp. 1357-1362
Open Access | Times Cited: 24

Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study
Sara Tartaglione, Teresa Granato, Emanuela Anastasi, et al.
Biochemia Medica (2019) Vol. 29, Iss. 2, pp. 352-358
Open Access | Times Cited: 22

The need for effective pancreatic cancer detection and management: a biomarker-based strategy
Aoife Crawley, Richard O’Kennedy
Expert Review of Molecular Diagnostics (2015) Vol. 15, Iss. 10, pp. 1339-1353
Closed Access | Times Cited: 21

Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression
Radim Moravec, Rao L. Divi, Mukesh Verma
World Journal of Gastrointestinal Oncology (2017) Vol. 9, Iss. 6, pp. 235-235
Open Access | Times Cited: 21

Expression of Epithelial and Mesenchymal Markers in Plasmatic Extracellular Vesicles as a Diagnostic Tool for Neoplastic Processes
Begoña Otero‐Alén, Lara Sofía Estévez-Pérez, María Otero Alén, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3578-3578
Open Access | Times Cited: 6

Metabolomics Analysis of Marker Metabolites for Patients with Pancreatic Cancer
Xijun Wang
Medicinal Chemistry (2014) Vol. 4, Iss. 6
Open Access | Times Cited: 16

Higher Expression of Talin-1 is Associated With Less Aggressive Tumor Behavior in Pancreatic Cancer
Samira Ahmadi Jazi, Fatemeh Tajik, Fereshteh Rezagholizadeh, et al.
Applied immunohistochemistry & molecular morphology (2024)
Closed Access | Times Cited: 1

Mesenchymal‐like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial‐like counterparts
Arkadeep Sinha, David Cherba, Heather Bartlam, et al.
Molecular Oncology (2014) Vol. 8, Iss. 7, pp. 1253-1265
Open Access | Times Cited: 9

Biomaterial-based in vitro models for pancreatic cancer
Eirini Velliou, Priyanka Gupta, Claudio Ricci, et al.
Elsevier eBooks (2020), pp. 235-249
Closed Access | Times Cited: 7

Development of a metabolite calculator for diagnosis of pancreatic cancer
Munseok Choi, Minsu Park, Sung Hwan Lee, et al.
Cancer Medicine (2023) Vol. 12, Iss. 15, pp. 15933-15944
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top